Capital World Investors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
AC
SCM
Capital World Investors's BLUE Position: Q1 2021 in Review
Capital World Investors sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 241,417 shares — an estimated $135M sold.
Capital World Investors first reported a position in BLUE in Q4 2014 and held it in 25 quarters. The position peaked at $633M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.
- Capital World Investors reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
- Capital World Investors sold 241,417 bluebird bio shares in Q1 2021, an estimated $135M.
- Capital World Investors first reported a position in bluebird bio in Q4 2014 and held it in 25 quarters.
- Capital World Investors's bluebird bio position peaked at $633M in Q1 2019.
- 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.
Based on Capital World Investors's 13F filing for Q1 2021, filed 14 May 2021.